Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 17 studies | 39% ± 13% | |
peripheral blood | 15 studies | 32% ± 11% | |
intestine | 11 studies | 30% ± 14% | |
brain | 10 studies | 31% ± 11% | |
kidney | 9 studies | 38% ± 9% | |
eye | 8 studies | 39% ± 18% | |
liver | 6 studies | 30% ± 16% | |
bone marrow | 5 studies | 23% ± 7% | |
lymph node | 5 studies | 41% ± 17% | |
pancreas | 4 studies | 65% ± 19% | |
uterus | 4 studies | 51% ± 16% | |
breast | 4 studies | 32% ± 4% | |
placenta | 3 studies | 38% ± 17% | |
adrenal gland | 3 studies | 33% ± 10% | |
prostate | 3 studies | 27% ± 6% | |
thymus | 3 studies | 40% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4828.44 | 1445 / 1445 | 100% | 18.64 | 183 / 183 |
ovary | 100% | 3646.15 | 180 / 180 | 100% | 24.49 | 430 / 430 |
uterus | 100% | 4573.36 | 170 / 170 | 100% | 16.87 | 459 / 459 |
brain | 100% | 7707.15 | 2641 / 2642 | 100% | 13.35 | 704 / 705 |
intestine | 100% | 4715.07 | 966 / 966 | 100% | 20.11 | 525 / 527 |
prostate | 100% | 4719.96 | 245 / 245 | 100% | 16.72 | 500 / 502 |
bladder | 100% | 4788.76 | 21 / 21 | 99% | 19.30 | 501 / 504 |
stomach | 100% | 3353.55 | 359 / 359 | 99% | 21.54 | 284 / 286 |
skin | 100% | 4979.73 | 1808 / 1809 | 99% | 13.35 | 467 / 472 |
kidney | 100% | 5811.04 | 89 / 89 | 99% | 14.65 | 889 / 901 |
breast | 100% | 4176.32 | 459 / 459 | 98% | 13.44 | 1101 / 1118 |
thymus | 100% | 4303.23 | 652 / 653 | 98% | 13.85 | 595 / 605 |
lung | 100% | 4372.86 | 576 / 578 | 97% | 11.13 | 1116 / 1155 |
adrenal gland | 100% | 4989.00 | 258 / 258 | 96% | 18.82 | 220 / 230 |
pancreas | 92% | 1466.19 | 302 / 328 | 98% | 15.15 | 175 / 178 |
liver | 95% | 1534.65 | 215 / 226 | 87% | 10.57 | 354 / 406 |
adipose | 100% | 4166.61 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6329.00 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 21.01 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 18.69 | 29 / 29 |
spleen | 100% | 3501.46 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 12.76 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 32.45 | 1 / 1 |
muscle | 99% | 3256.18 | 796 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 3981.21 | 848 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 3396.78 | 911 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007632 | Biological process | visual behavior |
GO_0007018 | Biological process | microtubule-based movement |
GO_0097542 | Cellular component | ciliary tip |
GO_0005874 | Cellular component | microtubule |
GO_0005813 | Cellular component | centrosome |
GO_0005929 | Cellular component | cilium |
GO_0005868 | Cellular component | cytoplasmic dynein complex |
GO_0030286 | Cellular component | dynein complex |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0045505 | Molecular function | dynein intermediate chain binding |
GO_0005515 | Molecular function | protein binding |
GO_0003777 | Molecular function | microtubule motor activity |
Gene name | DYNLRB1 |
Protein name | Dynein light chain roadblock-type 1 (Bithoraxoid-like protein) (BLP) (Dynein light chain 2A, cytoplasmic) (Dynein-associated protein Km23) (Roadblock domain-containing protein 1) Dynein light chain roadblock-type 1 |
Synonyms | BITH DNLC2A HSPC162 DNCL2A ROBLD1 |
Description | FUNCTION: Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. . FUNCTION: Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. . |
Accessions | ENST00000374846.3 B1AKR6 ENST00000480759.1 [Q9NP97-2] ENST00000300469.13 [Q9NP97-2] A0A8V8TKK9 ENST00000357156.7 [Q9NP97-1] Q9NP97 ENST00000696986.1 |